Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 12(7): e0181892, 2017.
Article in English | MEDLINE | ID: mdl-28715509

ABSTRACT

[This corrects the article DOI: 10.1371/journal.pone.0054463.].

2.
Neurobiol Learn Mem ; 107: 93-100, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24291571

ABSTRACT

We have previously shown that auditory Pavlovian fear conditioning is associated with an increase in DNA methyltransferase (DNMT) expression in the lateral amygdala (LA) and that intra-LA infusion or bath application of an inhibitor of DNMT activity impairs the consolidation of an auditory fear memory and long-term potentiation (LTP) at thalamic and cortical inputs to the LA, in vitro. In the present study, we use awake behaving neurophysiological techniques to examine the role of DNMT activity in memory-related neurophysiological changes accompanying fear memory consolidation and reconsolidation in the LA, in vivo. We show that auditory fear conditioning results in a training-related enhancement in the amplitude of short-latency auditory-evoked field potentials (AEFPs) in the LA. Intra-LA infusion of a DNMT inhibitor impairs both fear memory consolidation and, in parallel, the consolidation of training-related neural plasticity in the LA; that is, short-term memory (STM) and short-term training-related increases in AEFP amplitude in the LA are intact, while long-term memory (LTM) and long-term retention of training-related increases in AEFP amplitudes are impaired. In separate experiments, we show that intra-LA infusion of a DNMT inhibitor following retrieval of an auditory fear memory has no effect on post-retrieval STM or short-term retention of training-related changes in AEFP amplitude in the LA, but significantly impairs both post-retrieval LTM and long-term retention of AEFP amplitude changes in the LA. These findings are the first to demonstrate the necessity of DNMT activity in the consolidation and reconsolidation of memory-associated neural plasticity, in vivo.


Subject(s)
Amygdala/enzymology , Amygdala/physiology , DNA Modification Methylases/physiology , Memory/physiology , Neuronal Plasticity/physiology , Acoustic Stimulation , Animals , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , DNA Modification Methylases/antagonists & inhibitors , Decitabine , Enzyme Inhibitors/pharmacology , Fear/physiology , Male , Memory/drug effects , Mental Recall/drug effects , Mental Recall/physiology , Neuronal Plasticity/drug effects , Phthalimides/pharmacology , Rats , Rats, Sprague-Dawley , Tryptophan/analogs & derivatives , Tryptophan/pharmacology
3.
PLoS One ; 8(1): e54463, 2013.
Article in English | MEDLINE | ID: mdl-23349897

ABSTRACT

The study of the cellular and molecular mechanisms underlying the consolidation and reconsolidation of traumatic fear memories has progressed rapidly in recent years, yet few compounds have emerged that are readily useful in a clinical setting for the treatment of anxiety disorders such as post-traumatic stress disorder (PTSD). Here, we use a combination of biochemical, behavioral, and neurophysiological methods to systematically investigate the ability of garcinol, a naturally-occurring histone acetyltransferase (HAT) inhibitor derived from the rind of the fruit of the Kokum tree (Garcina indica), to disrupt the consolidation and reconsolidation of Pavlovian fear conditioning, a widely studied rodent model of PTSD. We show that local infusion of garcinol into the rat lateral amygdala (LA) impairs the training and retrieval-related acetylation of histone H3 in the LA. Further, we show that either intra-LA or systemic administration of garcinol within a narrow window after either fear conditioning or fear memory retrieval significantly impairs the consolidation and reconsolidation of a Pavlovian fear memory and associated neural plasticity in the LA. Our findings suggest that a naturally-occurring compound derived from the diet that regulates chromatin function may be useful in the treatment of newly acquired or recently reactivated traumatic memories.


Subject(s)
Anxiety Disorders/drug therapy , Fear , Memory/drug effects , Stress Disorders, Post-Traumatic/drug therapy , Terpenes/administration & dosage , Animals , Anxiety Disorders/complications , Anxiety Disorders/physiopathology , Brain/drug effects , Brain/physiopathology , Chromatin/drug effects , Fear/drug effects , Fear/psychology , Garcinia/chemistry , Histone Acetyltransferases/antagonists & inhibitors , Histone Acetyltransferases/metabolism , Humans , Neuronal Plasticity/drug effects , Rats, Sprague-Dawley , Stress Disorders, Post-Traumatic/complications , Stress Disorders, Post-Traumatic/physiopathology
4.
Learn Mem ; 20(2): 109-19, 2013 Jan 17.
Article in English | MEDLINE | ID: mdl-23328899

ABSTRACT

Modifications in chromatin structure have been widely implicated in memory and cognition, most notably using hippocampal-dependent memory paradigms including object recognition, spatial memory, and contextual fear memory. Relatively little is known, however, about the role of chromatin-modifying enzymes in amygdala-dependent memory formation. Here, we use a combination of biochemical, behavioral, and neurophysiological methods to systematically examine the role of p300/CBP histone acetyltransferase (HAT) activity in the consolidation and reconsolidation of auditory Pavlovian fear memories. We show that local infusions of c646, a selective pharmacological inhibitor of p300/CBP activity, shortly following either fear conditioning or fear memory retrieval impair training and retrieval-related regulation of histone acetylation in the lateral nucleus of the amygdala (LA). Furthermore, we show that intra-LA infusion of c646 significantly impairs fear memory consolidation, reconsolidation, and associated neural plasticity in the LA. Our findings collectively suggest that p300/CBP HAT activity is critical for the consolidation and reconsolidation of amygdala-dependent Pavlovian fear memories.


Subject(s)
Amygdala/physiology , Conditioning, Classical/physiology , Fear , Memory/physiology , p300-CBP Transcription Factors/metabolism , Acetylation/drug effects , Acoustic Stimulation , Amygdala/drug effects , Analysis of Variance , Animals , Conditioning, Classical/drug effects , Electrodes, Implanted , Electroshock , Enzyme Inhibitors/adverse effects , Enzyme Inhibitors/pharmacology , Evoked Potentials, Auditory/drug effects , Evoked Potentials, Auditory/physiology , Male , Memory/drug effects , Memory Disorders/chemically induced , Rats , Rats, Sprague-Dawley , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...